Increased risk of lung cancer among patients with bronchiectasis: A nationwide cohort study

QJM: An International Journal of Medicine

Volumn 109, Issue 1, 2016, Pages 17-25

  Chung, W S ^a,b,c   Lin, C L ^d,e   Hsu, W H ^d,f   Kao, C H ^d,f  

^a Taichung Hospital   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRONCHIECTASIS; CANCER RISK; COHORT ANALYSIS; DATA BASE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NATIONAL HEALTH INSURANCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TAIWAN; YOUNG ADULT; AGE; COMORBIDITY; FACTUAL DATABASE; INCIDENCE; LUNG NEOPLASMS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BRONCHIECTASIS; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX FACTORS; TAIWAN; YOUNG ADULT;

EID: 84964607468     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcu237     Document Type: Article

References (37)

1. WHO. GLOBOCAN 2012 (IARC): Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Fact sheets 2012. http://globocan.iarc.fr/Pages/fact_sheets_ cancer.aspx (1 June 2014, date last accessed).
2. Chiang CJ, Chen YC, Chen CJ, You SL, Lai MS. Cancer trends in Taiwan. Jpn J Clin Oncol 2010; 40:897-904.
3. Wang BY, Huang JY, Cheng CY, Lin CH, Ko J, Liaw YP. Lung cancer and prognosis in taiwan: a population-based cancer registry. J Thorac Oncol 2013; 8:1128-35.
4. Dubey S, Powell CA. Update in lung cancer 2007. Am J Respir Crit Care Med 2008; 177:941-6.
5. Pallis AG, Syrigos KN. Lung cancer in never smokers: disease characteristics and risk factors. Crit Rev Oncol Hematol 2013; 88:494-503.
6. Gale NS, Bolton CE, Duckers JM, Enright S, Cockcroft JR, Shale DJ. Systemic comorbidities in bronchiectasis. Chron Respir Dis 2012; 9:231-8.
7. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, Soler-Cataluná JJ, Carratalá A, Yago M, et al. The association between bronchiectasis, systemic inflammation, and tumor necrosis factor alpha. Arch Bronconeumol 2008; 44:8-14.
8. Mills NL, Miller JJ, Anand A, Robinson SD, Frazer GA, Anderson D, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008; 63:306-11.
9. Sunny SS, Burns A, Aspray T, Soyza AD. P90 Osteoporosis in non-cystic fibrosis bronchiectasis (NCFBr) Adults. Thorax 2012; 67:A102-A3.
10. Dave R, Arroliga A, Prince-Fiocco M. Osteoporosis and osteopenia in patients with non-cystic fibrosis (non-CF) bronchiectasis [abstract]. Chest 2009; 136:9Se.
11. O'Callaghan DS, O'Donnell D, O'Connell F, O'Byrne KJ. The role of inflammation in the pathogenesis of non-small cell lung cancer. J Thorac Oncol 2010; 5:2024-36.
12. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140:883-99.
13. Wang H, Yang L, Zou L, Huang D, Guo Y, Pan M, et al. Association between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysis. PLoS One 2012; 7:e46144.
14. Shen TC, Chung WS, Lin CL, Wei CC, Chen CH, Chen HJ, et al. Does chronic obstructive pulmonary disease with or without type 2 diabetes mellitus influence the risk of lung cancer? Result from a population-based cohort study. PLoS One 2014; 9:e98290.
15. Shiels MS, Albanes D, Virtamo J, Engels EA. Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 2011; 20:672-8.
16. Yu YH, Liao CC, Hsu WH, Chen HJ, Liao WC, Muo CH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol 2011; 6:32-7.
17. Cheng TM. Taiwan's National Health Insurance system: high value for the dollar. In: Okma KGH, Crivelli L, eds, Six Countries, Six Reform Models: The Health Reform Experience of Israel, the Netherlands, New Zealand, Singapore, Switzerland and Taiwan. New Jersey: World Scientific, 2009:71-204.
18. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug saf 2011; 20:236-42.
19. Chung WS, Lin CL, Peng CL, Chen YF, Lu CC, Sung FC, et al. Rheumatoid arthritis and risk of acute myocardial infarction- a nationwide retrospective cohort study. Int J Cardiol 2013; 168:4750-4.
20. Powell HA, Iyen-Omofoman B, Baldwin DR, Hubbard RB, Tata LJ. Chronic obstructive pulmonary disease and risk of lung cancer: the importance of smoking and timing of diagnosis. J Thorac Oncol 2013; 8:6-11.
21. Matysiak-Budnik T, Megraud F. Helicobacter pylori infection and gastric cancer. Eur J Cancer 2006; 42:708-16.
22. Di Bisceglie AM. Hepatitis B and hepatocellular carcinoma. Hepatology 2009; 49:S56-60.
23. Ning BF, Ding J, Liu J, Yin C, Xu WP, Cong WM, et al. Hepatocyte nuclear factor 4alpha-nuclear factor-kappaB feedback circuit modulates liver cancer progression. Hepatology 2014; 60:1607-19.
24. Zaghloul MS. Bladder cancer and schistosomiasis. J Egypt Natl Canc Inst 2012; 24:151-9.
25. Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, et al. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect 2006; 12:782-6.
26. Ding SZ, Goldberg JB, Hatakeyama M. Helicobacter pylori infection, oncogenic pathways and epigenetic mechanisms in gastric carcinogenesis. Future Oncol 2010; 6:851-62.
27. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441:431-6.
28. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66:605-12.
29. Henley SJ, Richards TB, Underwood JM, Eheman CR, Plescia M, McAfee TA. Lung cancer incidence trends among men and women-United States, 2005-2009. MMWR Morb Mortal Wkly Rep 2014; 63:1-5.
30. De Matteis S, Consonni D, Lubin JH, Tucker M, Peters S, Vermeulen R, et al. Impact of occupational carcinogens on lung cancer risk in a general population. Int J Epidemiol 2012; 41:711-21.
31. Consonni D, De Matteis S, Lubin JH, Wacholder S, Tucker M, Pesatori AC, et al. Lung cancer and occupation in a population-based case-control study. Am J Epidemiol 2010; 171:323-33.
32. Zhou YM, Wang C, Yao WZ, Chen P, Kang J, Huang SG, et al. The prevalence and risk factors of bronchiectasis in residents aged 40 years old and above in seven cities in China. Zhonghua nei ke za zhi 2013; 52:379-82.
33. Eklund BM, Nilsson S, Hedman L, Lindberg I. Why do smokers diagnosed with COPD not quit smoking?-a qualitative study. Tob Induc Dis 2012; 10:17.
34. Shah RS, Cole JW. Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 2010; 8:917-32.
35. Ockene IS, Miller NH. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997; 96:3243-7.
36. Jaakkola JJ, Gissler M. Maternal smoking in pregnancy, fetal development, and childhood asthma. Am J Public Health 2004; 94:136-40.
37. Yeh CC, Wang HH, Chou YC, Hu CJ, Chou WH, Chen TL, et al. High risk of gastrointestinal hemorrhage in patients with epilepsy: a nationwide cohort study. Mayo Clin Proc 2013; 88:1091-8.